Reportlinker Adds World Genetic Testing Market Report

NEW YORK--(Business Wire)--
Reportlinker.com announces that a new market research report is available in its
catalogue.

World Genetic Testing Market

http://www.reportlinker.com/p098275/World-Genetic-Testing--Market.html

This report analyzes the worldwide markets for Genetic Testing in Millions of
US$. The report provides separate comprehensive analytics for the US, Canada,
Japan, Europe, and Rest of World. Annual forecasts are provided for each region
for the period of 2000 through 2015. The report profiles 79 companies including
many key and niche players worldwide such as Abbott Laboratories, Abbott
Molecular Inc., Applied Biosystems Inc., AutoGenomics, Inc., BioRad
Laboratories, Celera Group, Clinical Data, Inc., Genzyme Genetics, Orchid
Cellmark, Inc., PerkinElmer, Inc., Quest Diagnostics, Inc., Roche Diagnostics,
Corp., Roche Molecular Diagnostics Inc., and Sciona Ltd. Market data and
analytics are derived from primary and secondary research. Company profiles are
mostly extracted from URL research and reported select online sources.

GENETIC TESTING MCP-1392 A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data
Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3 Prenatal Diagnosis I-3 Newborn
Screening I-3 Pharmacogenetics/Pharmacogenomics I-3 Predictive Testing I-4

II. EXECUTIVE SUMMARY

1. Overview II-1 Progressing from Service Driven to Product-Driven Market II-1
Genetic Testing Outlook Brightens II-1 Issues & Trends Affecting the Market II-1
Challenges Faced II-1 Online Approach Gains Momentum II-2 Recommendations of
ACOG and ACGM Augments Demand for CF Testing II-2 Ethical Issues & Need for
Appropriate Regulating Policies II-3 Routine Clinical Testing Vs. Predictive
Genetic Testing II-3 Issues Related to Genetic Tests for Obesity II-4
Competition II-4

Table 1: Leading Players in the Worldwide Genetic Testing Market (2005):
Percentage Breakdown by Value Sales for Roche Diagnostics / Affymetrix, Abbott
Laboratories, Bio-Rad Laboratories, and Others (includes corresponding
Graph/Chart) II-4

2. Product Overview II-5 Preface to Genetic Testing II-5 Genetic Testing and its
Applications II-5 Gene Candidate and Genome Screen II-6 `DNA Chip` to Chip into
Genetic Field II-6 Techniques Used to Identify Changes in Genes II-6 Types of
Genetic Testing II-7 Steps in Genetic Testing Process II-8 Limitations II-9
Risks and Other Limitations of Genetic Testing II-9 Medical Institutions to Reap
the Benefits of Genetic Testing II-9 Pharmacogenetics/Pharmacogenomics II-9
Review of Select Genetic Tests II-10 Cystic Fibrosis II-10 Breast and Ovarian
Cancer II-10 Alzheimer's Disease II-10 Colorectal Cancer II-10 Haemochromatosis
(HH) II-10 Cowden Syndrome II-11 Huntington's Disease II-11 Costs of Select
Tests II-11

Table 2: Costs of Select Genetic Tests (includes corresponding Graph/Chart)
II-11

3. Product Launches II-12 Clinical Data Introduces Genetic Test for HCM II-12
Iverson Genetic Diagnostics Unveils Warfarin Sensitivity Tests II-12 HairDX
Unveils New Test for Predicting Female Hair Loss II-12 HairDX Introduces Genetic
Test for Male Baldness II-12 Clinical Data Introduces Pharmacogenetic Test for
Clozapine II-13 Seegene Launches 18-Plex Genotyping Test II-13 InterGenetics
Introduces Onco Vue II-13 Applied Biosystems Introduces Novel DNA Technologies
II-14 Dabur Introduces CML Quest II-14 deCODE Launches deCODE T2 II-14 DNAPrint
Announces the Launch of Ancestry Indicator II-14 Genzyme Unveils New Mutation
Analysis Test II-15 Orchid BioSciences Introduces New Testing Kit II-15 Focus
Diagnostics Introduces GenomEx(TM) Service II-15 Relative Genetics Introduces
Y-chromosome haplogroup Service on Web Site II-15 Genzyme Unveils Upgraded
CFplus Cystic Fibrosis (CF) Mutation Analysis II-15 TMC Introduces AJP II-16
Genaissance Rolls Out FAMILION Test II-16 Tm Bioscience Rolls Out Tag-It
Mutation Detection Kits II-16

4. Recent Industry Activity II-17 Pfizer Animal Health to Take Over Bovigen and
Catapult Genetics II-17 DNA Testing Systems Inks Agreement with DNAPrint
Genomics II-17 PerkinElmer Acquires Newborn Metabolic Screening Assets of
Pediatrix II-17 Hologic Acquires Third Wave II-17 Dako Denmark Receives FDA
Approval for TOP2A FISH pharmDx Device II-18 Abbott Partners with Roche, OSI and
Genentech II-18 Lab21 Partners with Amgen II-18 Medical Solutions Acquires
Autogen Bioclear II-19 Nanobac to Acquire DNAPrint Genomics II-19 HairDX and
Bosley Join Hands for Offering Genetic Test for Baldness II-19 Nioxin Inks
Agreement with HairDX II-20 Orchid Cellmark Acquires ReliaGene Technologies
II-20 Celera Takes Over Atria Genetics II-20 Roche Acquires 454 Life Sciences
II-20 BioServe and DNAPrint Genomics Form Strategic Alliance II-21 Gentris
Divests Stake in Genetic Testing Unit II-21 LabCorp Announces Genetic Test
Partnership for Bucindolol Prescription II-21 Newsham Genetics Takes Over
Monsanto Choice Genetics II-21 BioServe Takes Over Genomics Collaborative II-22
CytoDyn Completes Acquisition of Advanced Genetic Technologies II-22 Sorenson
Genomics Takes Over Identigene II-22 Clinical Data Enters into a License
Agreement with VCGS II-22 Clinical Data Collaborates with George Washington
University II-23 Luminex Takes Over TM Bioscience II-23 Schering-Plough Enters
into a Contract with Warnex II-23 Cepheid Acquires Sangtec II-24 Medco
Collaborates with Mayo II-24 Lab21 to Offer CLDA`s Genetic Test for Cardiac
Channelopathy II-24 Clinical Data Pockets Epidauros Biotechnologie II-24 Beijing
Adinovo Gene and GENDIA Ink Genetic Test Exchange Agreement II-25 Genetic
Technologies Forms Alliance with UTEK II-25 QIAGEN Acquires Digene II-25 Luminex
Inks Development Licensing Agreement with Mayo Clinic II-25 Manipal Joins Hands
with NorDiag II-26 Orchid BioSceinces Enters into an Agreement with Prion
Diagnostica II-26 DNAPrint genomics to Purchase Ellipsis II-26 Tm Bioscience
Inks a Pact with Maxxam Analytics II-26 DNAPrint genomics Takes Over Trace
Genetics II-27 Roche Diagnostics Inks a Licensing Agreement with Innogenetics
II-27 Clinical Data Purchases Genaissance Pharmaceuticals II-27 Illumina Pockets
CyVera Corporation II-27 Orchid Cellmark Inks Contract with Merial II-27
Sequenom Gains Noninvasive Prenatal Diagnostic IP Rights from Isis II-27 TMC
Inks a Pact with ARUP Laboratories II-28 Specialty Laboratories Accords with
Roche II-28 TMC Ceases Licensing Agreement with Abbott II-28 Correlagen
Diagnostics Collaborates with Children's Hospital Boston II-28 Edith Cowan
University Strikes Deal with Solbec II-28 InterGenetics Join Hands with
i.d.e.a.s. II-28 Clinical Data Acquires Icoria II-29 SomaLogic Strikes a Deal
with Quest Diagnostics II-29 DNAPrint Bags Grant from the Federal Government
II-29 Tepnel Acquires Orchid`s Diagnostic Unit II-29 Lark Tech. Merges with
Genaissance II-29 PRF in Alliance with Sydney Biotech II-29 Osmetech and LGC
Sign Licensing Pact II-30 TMC Signs a Pact with LabOne II-30 Abbott in Agreement
with Atria II-30 Third Wave Grants Marketing and Distribution Rights to
Innogenetics II-30 Orchid Bags Deal to Provide Testing Services to Immigrants to
New Zealand II-30 Tm Bioscience Contracts with Pharmacogenetics II-31 Genetic
Technologies Grants License to Genzyme II-31 New Genetic Testing Identifies Gene
Responsible for Alzheimer Disease II-31 Roche Licenses GeneChip Technology from
Affymetrix II-31 Genaissance Acquires DNA Sciences II-31 GTG Joins GENDIA
Diagnostic Genetic Testing Network II-31 Arch Collaborates with GeneLink to
Market Formulations II-32 Roche Diagnostics and GIS to Develop SARS Detection
Kit II-32 Roche Diagnostics in Agreement with Innogenetics II-32 Cenetron in
Alliance with Roche Diagnostics II-32 Gribbles Establishes Gribbles Molecular
Science, a New Genetic Testing Firm II-32 Roche the First to Receive Clearance
for Thrombophilia Genetic Disorder Tests II-33 Roche and DeCode Develop
DNA-based Tests to Foretell Behavior II-33 Roche and deCODE Discover Changes in
Gene Responsible for Osteoporosis II-33 Roche and deCODE Announce Discovery of
New Gene Structures II-33 Mayo Contracts with Tm Bioscience II-33

5. Technological Developments - Recent Past data II-34 New Molecular Diagnostic
device to Improve Genetic Tests for Alzheimer disease II-34 Deakin Clinic Offers
PGD, a Sophisticated Testing for Genetic Disorders II-34 New Gene Mapping Method
to Enhance Identification of Haplotype Block II-34 New Non-Invasive test a
Better Indicator of Malignancy than the PSA Test II-34

6. Focus on Select Global Players II-35 Abbott Laboratories (USA) II-35 Abbott
Molecular Inc. (USA) II-35 Applied Biosystems Inc. (USA) II-35 AutoGenomics,
Inc. (USA) II-35 BioRad Laboratories (USA) II-36 Celera Group (USA) II-36
Clinical Data, Inc. (USA) II-36 Genzyme Genetics (USA) II-36 Orchid Cellmark,
Inc (USA) II-37 PerkinElmer Inc., (USA) II-37 Quest Diagnostics, Inc. (USA)
II-37 Roche Diagnostics, Corp. (Switzerland) II-38 Roche Molecular Diagnostics
Inc. (USA) II-38 Sciona, Limited. (USA) II-38

7. Global Market Perspective II-39

Table 3: World Recent Past, Current & Future Market Analysis for Genetic Testing
by Geographic Region - US, Canada,Japan, Europe and Rest of World Independently
Analyzedwith Annual Sales Figures in US$ Million for Years 2000 through 2010
(includes corresponding Graph/Chart) II-39

Table 4: World long-term projections for Genetic Testing by Geographic Region -
US, Canada,Japan, Europe and Rest of World Independently Analyzedwith Annual
Sales Figures in US$ Million for Years 2011through 2015 (includes corresponding
Graph/Chart) II-40

Table 5: World 10-Year Perspective for Genetic Testing by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe and Rest of
World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)
II-41

III. MARKET

1. The United States III-1 A.Market Analysis III-1 Current and Future Analysis
III-1 Newborn Testing Gain Ground III-1

Table 6: US Prenatal and Newborn Genetic Testing Market (2000-2005): Annual
Sales in US$ Million (includes corresponding Graph/Chart) III-1 Predictive
Screening -Another Growth Area III-2 Direct-to-Consumer Testing- A Growing
Market III-2 US Regulatory Environment III-2 Genetic Testing Set for Big Boost
with New Legislation III-3 DNA-Based Testing to Move Beyond Research
Laboratories III-3 Key and Emerging Players in US III-3 Abbott Laboratories
III-3 Abbott Molecular Inc. III-4 Applied Biosystems Inc. III-4 AutoGenomics,
Inc. III-4 BioRad Laboratories III-4 Celera Group III-5 Clinical Data, Inc.
III-5 Genova Diagnostics III-5 Genzyme Genetics III-6 InterGenetics III-6 Myriad
Genetic Laboratories, Inc. III-6 Nanogen, Inc. III-6 Orchid Cellmark, Inc III-7
PerkinElmer, Inc III-7 Quest Diagnostics, Inc. III-7 Roche Molecular Diagnostics
Inc. III-8 Sciona, Limited. III-8 Product Launches III-8 Strategic Developments
III-12 B.Market Analytics III-23

Table 7: US Recent Past, Current & Future Analysis for Genetic Testing by
Segment-Pharmacogenomic Testing, Prenatal and Newborn Genetic Testing, and
Predictive Medicine Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)
III-23

Table 8: US Long-term Projections for Genetic Testing by Segment-Pharmacogenomic
Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011
through 2015 (includes corresponding Graph/Chart) III-23

Table 9: US 10-Year Perspective for Genetic Testing by Segment-Pharmacogenomic
Testing, Prenatal and Newborn Genetic Testing, and Predictive Medicine Markets
for 2003, 2008 & 2012 (includes corresponding Graph/Chart) III-24

2. Canada III-25 A.Market Analysis III-25 Canada, the Market to be Watched Out
for III-25 Key Player III-25 Luminex Molecular Diagnostics III-25 Product
Launches III-25 Strategic Developments III-26 B.Market Analytics III-27

Table 10: Canadian Recent Past, Current & Future Analysis for Genetic Testing -
Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-27

Table 11: Canadian Long-term Projections for Genetic Testing - Annual Sales
Figures with Annual Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-28

3. Japan III-29 Market Analysis III-29

Table 12: Japanese Recent Past, Current & Future Analysis for Genetic Testing -
Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart). III-29

Table 13: Japanese Long-term Projections for Genetic Testing - Annual Sales
Figures with Annual Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-30

4. Europe III-31 A.Market Analysis III-31 A Brief Overview of
Legislations/Regulatory Policies in Select European Countries III-31 Government
Encourages Genetic Testing in UK III-31 Key and Emerging Players in Europe
III-32 Biotage AB (Sweden) III-32 IMGM Laboratories GmbH (Germany) III-33 Roche
Diagnostics, Corp. (Switzerland) III-33 Strategic Developments III-33 B.Market
Analytics III-39

Table 14: European Recent Past, Current & Future Analysis for Genetic Testing -
Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart). III-39

Table 15: European Long-term Projections for Genetic Testing - Annual Sales
Figures with Annual Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-39

5. Rest of World III-40 A.Market Analysis III-40 Asia & Latin America: The
Future Markets for Genetic Testing III-40 Approval of Experiments on Human
Embryos in New Zealand III-40 Singapore Sets Guidelines for Genetic Research and
Testing III-40 Product Launches III-41 Strategic Developments III-41 B.Market
Analytics III-42

Table 16: Rest of World market for Genetic Testing - Recent Past, Current &
Future Analysis with Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-42

Table 17: Rest of World (*) Market for Genetic Testing Long-term Projections
with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) III-43

IV. COMPETITIVE LANDSCAPE

-Abbott Laboratories (USA) -Affiliated Genetics, Inc (USA) -Affymetrix, Inc
(USA) -American Genetics, Inc (USA) -Applied Biosystems Group (USA)
-Autogenomics, Inc (USA) -Autoimmune Technologies LLC (USA) -Becton, Dickinson &
Company (USA) -Biogenetic Services, Inc (USA) -Bio-Rad Laboratories, Inc (USA)
-Bioscientia (Germany) -Biotage AB (Sweden) -BRT Laboratories, Inc (USA) -Celera
Diagnostics (USA) -Columbia Laboratory Services (USA) -Digene Corporation (USA)
-DNA Diagnostics Center (USA) -DNAPrint Genomics, Inc (USA) -Elan Corporation
PLC (Ireland) -Fujirebio Diagnostics, Inc (USA) -Genaissance Pharmaceuticals,
Inc (USA) -Genecare Medical Genetics Center (USA) -Genedx, Inc (USA) -Genelex
Corporation (USA) -Genetest Corporation (USA) -Genetic Profiles Laboratory (USA)
-Genetic Technologies, Inc (USA) -Genetica DNA Laboratories, Inc (USA) -Genetics
& IVF Institute (USA) -Genetree DNA Testing Center (USA) -Genex Diagnostics
Swabtest (USA) -Genomic Health, Inc (USA) -Genova Diagnostics (USA) -Gentra
Systems, Inc (USA) -Genzyme Genetics (USA) -Great Lakes Genetics, SC (USA)
-Gribbles Group Ltd (Australia) -Healthcheck USA (USA) -ID Labs Biotechnology
(Canada) -Identigene (USA) -Identity Genetics, Inc (USA) -IMGM Laboratories
(Germany) -Independent Forensics (USA) -Innogenetics NV (Belgium)
-Intergenetics, Inc (USA) -Interleukin Genetics, Inc (USA) -Investigen, Inc
(USA) -Invitrogen Corporation (USA) -Kimball Genetics, Inc (USA) -Laboratory
Corporation Of America Holdings (USA) -Lark Technologies, Inc (USA) -London
Biosciences Corporation (UK) -MDS Diagnostic Services (Canada) -Myriad Genetics,
Inc (USA) -Nanogen, Inc (USA) -Orchid Cellmark (USA) -Osmetech, Inc Critical
Care Division (USA)-Panomics, Inc (USA) -Paragon Genetics (USA) -Pediatrix
Screening (USA) -PerkinElmer, Inc (USA) -Proactive Genetics, Inc (USA) -PRO-DNA
Diagnostic (Canada) -Qiagen NV (The Netherlands) -Quest Diagnostics, Inc (USA)
-Reliagene Technologies, Inc (USA) -Roche Diagnostics (Switzerland) -Sciona, Inc
(USA) -Sequenom, Inc (USA) -St Josephs DNA Diagnostic Laboratories (USA) -Tepnel
Life Sciences PLC (UK) -Third Wave Technologies, Inc (USA) -TM Bioscience
Corporation (Canada) -Xtrana, Inc (USA)

To order this report:World Genetic Testing Market

http://www.reportlinker.com/p098275/World-Genetic-Testing--Market.html

More market research reports here!

Reportlinker
Nicolas: nbo@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

Copyright Business Wire 2009